Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
Rapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (>95%) but imperfect specificity, they are expected to generate...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4401675?pdf=render |
id |
doaj-97dfc3953ce5411b9393b9d2b8e35d8f |
---|---|
record_format |
Article |
spelling |
doaj-97dfc3953ce5411b9393b9d2b8e35d8f2020-11-24T21:34:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012300510.1371/journal.pone.0123005Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.Patrick NdaseConnie CelumLara KidoguchiAllan RonaldKenneth H FifeElizabeth BukusiDeborah DonnellJared M BaetenPartners PrEP Study TeamRapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (>95%) but imperfect specificity, they are expected to generate some false positive results.We assessed the frequency of true and false positive rapid results in the Partners PrEP Study, a randomized, placebo-controlled trial of PrEP. HIV testing was performed monthly using 2 rapid tests done in parallel with HIV enzyme immunoassay (EIA) confirmation following all positive rapid tests.A total of 99,009 monthly HIV tests were performed; 98,743 (99.7%) were dual-rapid HIV negative. Of the 266 visits with ≥1 positive rapid result, 99 (37.2%) had confirmatory positive EIA results (true positives), 155 (58.3%) had negative EIA results (false positives), and 12 (4.5%) had discordant EIA results. In the active PrEP arms, over two-thirds of visits with positive rapid test results were false positive results (69.2%, 110 of 159), although false positive results occurred at <1% (110/65,945) of total visits.When HIV prevalence or incidence is low due to effective HIV prevention interventions, rapid HIV tests result in a high number of false relative to true positive results, although the absolute number of false results will be low. Program roll-out for effective interventions should plan for quality assurance of HIV testing, mechanisms for confirmatory HIV testing, and counseling strategies for persons with positive rapid test results.http://europepmc.org/articles/PMC4401675?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Patrick Ndase Connie Celum Lara Kidoguchi Allan Ronald Kenneth H Fife Elizabeth Bukusi Deborah Donnell Jared M Baeten Partners PrEP Study Team |
spellingShingle |
Patrick Ndase Connie Celum Lara Kidoguchi Allan Ronald Kenneth H Fife Elizabeth Bukusi Deborah Donnell Jared M Baeten Partners PrEP Study Team Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. PLoS ONE |
author_facet |
Patrick Ndase Connie Celum Lara Kidoguchi Allan Ronald Kenneth H Fife Elizabeth Bukusi Deborah Donnell Jared M Baeten Partners PrEP Study Team |
author_sort |
Patrick Ndase |
title |
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. |
title_short |
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. |
title_full |
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. |
title_fullStr |
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. |
title_full_unstemmed |
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions. |
title_sort |
frequency of false positive rapid hiv serologic tests in african men and women receiving prep for hiv prevention: implications for programmatic roll-out of biomedical interventions. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2015-01-01 |
description |
Rapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (>95%) but imperfect specificity, they are expected to generate some false positive results.We assessed the frequency of true and false positive rapid results in the Partners PrEP Study, a randomized, placebo-controlled trial of PrEP. HIV testing was performed monthly using 2 rapid tests done in parallel with HIV enzyme immunoassay (EIA) confirmation following all positive rapid tests.A total of 99,009 monthly HIV tests were performed; 98,743 (99.7%) were dual-rapid HIV negative. Of the 266 visits with ≥1 positive rapid result, 99 (37.2%) had confirmatory positive EIA results (true positives), 155 (58.3%) had negative EIA results (false positives), and 12 (4.5%) had discordant EIA results. In the active PrEP arms, over two-thirds of visits with positive rapid test results were false positive results (69.2%, 110 of 159), although false positive results occurred at <1% (110/65,945) of total visits.When HIV prevalence or incidence is low due to effective HIV prevention interventions, rapid HIV tests result in a high number of false relative to true positive results, although the absolute number of false results will be low. Program roll-out for effective interventions should plan for quality assurance of HIV testing, mechanisms for confirmatory HIV testing, and counseling strategies for persons with positive rapid test results. |
url |
http://europepmc.org/articles/PMC4401675?pdf=render |
work_keys_str_mv |
AT patrickndase frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT conniecelum frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT larakidoguchi frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT allanronald frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT kennethhfife frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT elizabethbukusi frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT deborahdonnell frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT jaredmbaeten frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions AT partnersprepstudyteam frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions |
_version_ |
1725950587181203456 |